Mckenzie Brandt

Ms. Mckenzie Brandt

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
MBMckenzie Brandt
Mckenzie Brandt
JMJason Bradley Malone
Jason Bradley Malone
TKThomas J Kean
Thomas J Kean
Background/Objectives: Osteoarthritis (OA) is a highly prevalent, degenerative joint disease capable of causing severe pain and impaired mobility. Current treatments mitigate symptoms but do not cure the disease. The development of a disease-modifying osteoarthritis drug (DMOAD) could improve patient outcomes by slowing, halting, or reversing joint damage. Many DMOADs have progressed to clinical trials, but very few have made a significant impact, and none have been approved for clinical use. The purpose of this review is to present an update on the current status of DMOADs with a particular focus on results published since 2010. Methods: A comprehensive search was conducted within PubMed and ClinicalTrials.gov for novel DMOADs enrolled in phase II and III clinical trials between 1 January 2010 and 1 July 2024. Results: Eleven DMOAD candidates are reviewed and critically analyzed for their potential benefit in OA treatment—Lorecivivint (SM04690), TissueGene-C, Cindunistat (SD-6010), Sprifermin, UBX0101, TPX-100, GLPG1972/S201086, Lutikizumab (ABT-981), SAR113945, MIV-711, and LNA043—and relevant challenges to their development are discussed. Conclusions: Six DMOADs have demonstrated statistically significant evidence of a structural or symptomatic benefit without major safety concerns in phase II and III randomized controlled trials post-2010.

4 February 2026 in Journal of Orthopaedics
Verified
Journal Article
Closed access
QNQuintin Norris
Quintin Norris
VAVraj Amin
Vraj Amin
SHSamuel Hovland
Samuel Hovland
MBMckenzie Brandt
Mckenzie Brandt
DMDarius Moezzi
Darius Moezzi

1 January 2026 in Journal of Orthopaedic Case Reports
Verified
Journal Article
Open access
MBMckenzie Brandt
Mckenzie Brandt
MBMichael S Barnum
Michael S Barnum
JHJose A Herrera-Soto
Jose A Herrera-Soto
Introduction: Tibial shaft fractures are common pediatric injuries. Rigid intramedullary nails (RIMN) are widely used for the fixation of complex tibial shaft fractures in skeletally mature individuals, but their safety is debated in patients with open physes. There has been growing support for the use of RIMN fixation in pediatric patients due to the stability and rapid return to weight-bearing activities they offer. In this study, we evaluate the utility and safety of suprapatellar RIMN fixation in skeletally immature children with tibial shaft fractures. Materials and Methods: This retrospective case series includes seven skeletally immature patients treated with suprapatellar RIMN fixation of tibial shaft fractures at a single level one trauma center between May 1, 2009, and May 1, 2024. The primary outcome of interest was clinical signs of iatrogenic growth arrest. Secondary outcomes of interest included post-operative complications and time to full weight bearing (FWB), union, and sport. Results: The mean age at the time of operation was 13.7 years (range: 12–15) and the mean follow-up time was 14.21 months (range: 6–26.5). We observed no clinical evidence of iatrogenic growth arrest or limb deformity post-operatively. The mean time to union was 24.17 weeks. On average, patients returned to FWB and full activity/sport at 10.33 and 22.67 weeks, respectively. The majority of patients (n = 5) did not require hardware removal with the exception of one patient who developed a deep tissue infection and another with delayed union of an associated fibula fracture. Conclusion: In a series of seven skeletally immature children, suprapatellar RIMN fixation of tibial shaft fractures was not associated with iatrogenic growth arrest. Benefits of this fixation technique include an expedited return to weight-bearing activity and sport. Keywords: Intramedullary fixation, skeletally immature, tibial shaft fracture, orthopedic trauma, suprapatellar approach.


11 March 2026 in International Journal of Medical Students
Verified
Journal Article
Open access
PDF file
MBMckenzie Brandt
Mckenzie Brandt
QNQuintin Norris
Quintin Norris
LBLuke Van Blaricom
Luke Van Blaricom
LPLaurel Poole
Laurel Poole
SLStephen Lambert
Stephen Lambert
JKJonathan Kibble
Jonathan Kibble
Applying to medical school is a lengthy and competitive process and doing so as a couple adds a unique set of challenges. This article offers the personal experience of two medical students who applied and successfully matriculated to US medical schools during the same admissions cycle. By sharing our perspectives and advice from admissions professionals, we hope to aid prospective medical students who are navigating this unique circumstance.

2 February 2026 in Journal of Orthopaedic Experience & Innovation
Verified
Journal Article
Open access
PDF file
MBMckenzie Brandt
Mckenzie Brandt
MPMelanie K. Peterson
Melanie K. Peterson
RKRamsey C. Kinney
Ramsey C. Kinney
Introduction: Previous studies demonstrate that retired service members who undergo total joint arthroplasty (TJA) through the Veterans Affairs (VA) healthcare system experience poorer short-term outcomes than the general population. Given that many healthcare disparities were exacerbated during the COVID-19 pandemic, the aim of this study is to determine if veterans who underwent total knee arthroplasty (TKA) at a single VA medical center experienced poorer 30-day outcomes during versus before COVID-19. Methods: A retrospective review of electronic medical records was conducted to identify patients who underwent primary TKA between July 2017 and November 2021 at a single VA medical center. A total of 208 patients (n=238 knees) were included in the study and divided into two cohorts: TKAs performed before COVID-19 (July 2017-March 2020, n=143 knees) and TKAs performed during COVID-19 (June 2020-November 2021, n=95 knees). Inpatient outcomes of interest included length of stay (LOS), pain, opioid use, and physical therapy (PT) attendance and performance. Outpatient outcomes of interest included 30-day complication, readmission, and mortality. Results: Veterans in the COVID-19 group had a significantly shorter LOS (1.02 vs. 1.42 days) than the pre-pandemic group (p < 0.0001; d = -0.61, 95% CI: -0.87, -0.34). The COVID-19 group further demonstrated significantly greater PT attendance on postoperative day (POD) 0 (p = 0.0419; RR = 1.51, 95% CI: 0.98, 2.30), and reported less pain (p = 0.0185; d = -0.32, 95% CI: -0.58, -0.06), required fewer opioids (p < 0.0001; d = -0.59, 95% CI: -0.85, -0.32), and demonstrated superior PT performance on POD 1. There was no significant difference in 30-day complication, readmission, or mortality between groups. Conclusion: In general, veterans who underwent TKA during COVID-19 had better 30-day outcomes than their pre-pandemic counterparts, which is consistent with trends observed in the general population.